(2023). Prescribing of Low-dose Rivaroxaban in Patients with Atherosclerotic Cardiovascular Disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15708.
(2022). The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Rep, 17, 101614. http://doi.org/10.1016/j.bonr.2022.101614.
(2022). Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvac043.
(2022). Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum. Mult Scler, 13524585221094218. http://doi.org/10.1177/13524585221094218.
(2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. J Psychopharmacol, 2698811221082470. http://doi.org/10.1177/02698811221082470.
(2003). Use of alpha-blockers and the risk of hip/femur fractures. J Intern Med..
(2004). Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. http://doi.org/10.1136/hrt.2003.020180.
(2006). Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. http://doi.org/10.1111/j.1528-1167.2006.00596.x.
(2006). Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax. http://doi.org/10.1136/thx.2006.062885.
(2006). Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. http://doi.org/10.1212/01.wnl.0000210503.89488.88.